Genmab AS (GMAB) Stock Price
Genmab AS Price
Revenue has compounded at 19.0% per year over the past 19 years to 3.72 B USD. Earnings per share have grown at 17.3% per year over the last 12 years. Genmab AS's net margin stands at 25.9%, down from 35.1% several years earlier. Analysts set a median price target of 40.00 USD, implying 9.1% above the current price. Of 27 analysts, 22 rate the stock a buy — an overall Buy consensus.
Genmab AS stock price
Genmab AS business model & stock analysis
Frequently asked questions about Genmab AS
Analysts currently set an average price target of 38.60 USD for the Genmab AS stock (median: 40.00 USD), implying +5.3 % versus the latest price. The consensus is based on 27 analyst ratings.
27 analysts currently rate the Genmab AS stock: 22 recommend buying, 3 holding and 2 selling. For 2026, analysts expect Genmab AS to generate revenue of 4.48 B USD and earnings per share of 1.08 USD.
Converted at the current exchange rate, the Genmab AS share trades at 32.73 EUR (36.65 USD).
The expected revenue of Genmab AS is 4.48 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Genmab AS is 725.76 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Genmab AS is currently 33.97. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Genmab AS stock.
The price-to-sales ratio (P/S) of Genmab AS is currently 5.50. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Genmab AS stock.
The Eulerpool Quality Score for Genmab AS is 5/10.
The ISIN of Genmab AS is US3723032062. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Genmab AS is A1WZYB. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Genmab AS is GMAB. The ticker symbol is used to trade Genmab AS shares on the stock exchange.
Genmab AS stock
Genmab AS Peer Group
All fundamentals and in-depth analysis of Genmab AS
Our stock analysis for Genmab AS stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genmab AS. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.